Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT00329160
Eligibility Criteria:
Inclusion Criteria:
* Signed written informed consent,
* 20 to 75 years old,
* Plan to undergo coronary angiography (CAG) or Percutaneous coronary intervention (PCI) and LDL-C ≥ 140 mg/dL (untreated patients) or LDL-C ≥ 100 mg/dL (treated patients)
Exclusion Criteria:
* Acute myocardial infarction within 72 hours after the onset,
* Heart failure of New York Heart Association (NYHA) Class III or above,
* Serious arrhythmia,
* Being treated with LDL-apheresis
* History of serious reaction or hypersensitivity to other HMG-CoA reductase inhibitors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00329160
Study Brief:
Protocol Section:
NCT00329160